In 2019, CarnoSyn® beta-alanine established New Dietary Ingredient (NDI) status. Becoming an NDI ingredient reaffirms our commitment to deliver the highest-quality solutions to athletes and brand partners, and further distinguishes CarnoSyn® from generic forms of beta-alanine with questionable quality and effectiveness.
With self-affirmed GRAS status, you can be confident that CarnoSyn® is a safe and effective ingredient. Self-Affirmed GRAS status allows opportunities within the dietary supplement and food & beverage industries.
Over 55 clinical studies support the athletic performance benefits of CarnoSyn® beta-alanine. CarnoSyn® was proven to increase muscle carnosine and increase performance when athletes dosed with at least 3.2-6.4 grams of CarnoSyn® per day over a 28-day period.
20 GLOBAL PATENTS
Backed by years of scientific research, CarnoSyn® is the only patented beta-alanine on the market.
CarnoSyn® is the only beta-alanine imported and sold in the U.S licensed under NAI’s growing portfolio of U.S. and foreign patents. Ultimately, this ensures that any future advancements in sports nutrition research and technology related to beta-alanine will continue to benefit athletes around the world. Current patents issued globally include: